A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: Results from the GAIT study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 7, 2005, Pages 1489-1492

  Almasy, L ^a   Soria, J M ^b   Souto, J C ^b   Warren, D M ^a   Buil, A ^b   Borrell, M ^e   Munoz X ^c   Sala, N ^c   Lathrop, M ^d   Fontcuberta, J ^b   Blangero, J ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Institut de Recerca Oncologica   (Spain)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^e Southwest Foundation ^*

Author keywords

Association; Heritability; Linkage; TFPI

Indexed keywords

TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CHILD; CHROMOSOME 2; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOME ANALYSIS; HERITABILITY; HUMAN; IDIOPATHIC DISEASE; INFANT; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENOMICS; HUMANS; INFANT; LIPOPROTEINS; LOD SCORE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOSIS;

EID: 21544443131     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000166602.04711.2e     Document Type: Article

References (23)

1. Blann AD, Amiral J, McCollum CN, Lip GY. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis. 2000;152:29-34.
2. Moor E, Hamsten A, Karpe F, Bavenholm P, Blomback M, Silveira A. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infraction at a young age. Thromb Haemost. 1994;71:707-712.
3. Sakkinen PA, Cushman M, Psaty BM, Kuller LH, Bajaj SP, Sabharwal AK, Boineau R, Macy E, Tracy RP. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost. 1998; 80:134-139.
4. Abumiya T, Yamaguchi T, Terasaki T, Kokawa T, Kario K, Kato H. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients. Thromb Haemost. 1995;74:1050-1054.
5. Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariens RA. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol. 2001;113: 537-543.
6. Oksuzoglu G, Simsek H, Haznedaroglu IC, Kirazli S. Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis. Am J Gastroenterol. 1997;92:303-306.
7. Souto JC, Almasy L, Borrell M, Garf M, Martínez E, Mateo J, Stone W, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101:1546-1551.
8. Sandset PM, Larsen ML, Abilgaard U, Lindahl KA, Odergaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels of the normal population and relation to cholesterol. Blood Coagul Fibrinolysis. 1991;2:425-433.
9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988; 6:1215.
10. Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimura H, Kawasaki T, Kato HC. -399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb Haemost. 1998;80:345-346.
11. Kleesiek K, Schmidt M, Gotting C, Schwenz B, Lange S, Muller-Berghaus G, Brinkmann T, Prohaska W. The 536C->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost. 1999; 82:1-5.
12. Moatti D, Seknadji P, Galand C, Poirier O, Fumeron F, Desprez S, Garbarz M, Dhermy D, Arveiler D, Evans A, Luc G, Ruidavets JB, Ollivier V, Hakim J, Aumont MC, de Prost D. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects: impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol. 1999; 19:862-869.
13. Dyke B. PEDSYS: a pedigree data management system. User's Manual. Tech. Rep. No. 2. San Antonio, Tex: Southwest Foundation for Biomedical Research; 1995.
14. Almasy L, Blangero J. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
15. Almasy L, Blangero J. Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet. 2004;34:173-177.
16. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet. 1999;65:531-544.
17. Blangero J, Williams JT, Almasy L. Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol. 2000;19:S8-S14.
18. Boehnke M, Lange K. Ascertainment and goodness of fit of variance component models for pedigree data. Prog Ciin Biol Res. 1984;147: 173-192.
19. Feingold E, Brown PO, Siegmund D. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet. 1993;53:234-251.
20. Girard TJ, Eddy R, Wesselschmidt RL, MacPhail LA, Likert KM, Byers MG, Shows TB, Broze. Jr G.J. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. J Biol Chem. 1991;266: 5036-5041.
21. van der Logt CP, Reitsma PH, Bertina RM. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation. Biochemistry. 1991;30:1571-1577.
22. Moatti D, Haidar B, Fumeron F, Gaud L, Boudvillain O, Seknadji P, Olliver V, Aumont MC, de Prost DA. New T-287C polymorphism in the 5′ regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels. Thromb Haemost. 2000;84: 244-249.
23. Gonzalez-Conejero R, Lozano M-L, Corral J, Martinez C, Vicente V. The TFPI 536 C->T mutation is not associated with increased risk for venous or arterial thrombosis. Thromb Haemost. 2000;83:787-788.